Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
Myuran Thana, Naveen S. Basappa, Sunita Ghosh, Christian Kollmannsberger, Daniel Y.C. Heng, Aaron R. Hansen, Jeffery Graham, Denis Soulières, M. Neil Reaume, Aly‐Khan A. Lalani, Vincent Castonguay, Georg A. Bjarnason, François Patenaude, Rodney H. Breau, Frédéric Pouliot, Anil Kapoor, Lori Wood
Topics & Concepts
IpilimumabNivolumabMedicineDiscontinuationRenal cell carcinomaInternal medicineCohortOncologyKidney cancerAdverse effectExpanded accessCancerSurgeryImmunotherapyRenal cell carcinoma treatmentFerroptosis and cancer prognosisCancer Immunotherapy and Biomarkers